Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction

Schizophrenia (SZ) is among the twenty most disabling diseases worldwide. Subjective quality of life, well-being, and satisfaction are core elements to achieving personal recovery from the disorder. Long-acting injectable second-generation antipsychotics (SGA-LAIs) represent a valid therapeutic opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Brasso, Claudio, Bellino, Silvio, Bozzatello, Paola, Montemagni, Cristiana, Nobili, Marco Giuseppe Alberto, Sgro, Rodolfo, Rocca, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672596/
https://www.ncbi.nlm.nih.gov/pubmed/38002600
http://dx.doi.org/10.3390/jcm12226985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672596/
https://www.ncbi.nlm.nih.gov/pubmed/38002600
http://dx.doi.org/10.3390/jcm12226985

Ejemplares similares